Article Text
PDF
Statistics from Altmetric.com
- Trauma, research
- resuscitation, research
- resuscitation, clinical care
- resuscitation, effectiveness
- research, methods
To the Editor;
The article titled ‘Saving the critically injured trauma patient: a retrospective analysis of 1000 uses of intraosseous access’1 reaches conclusions that are not supported by their data or other existing literature.
Existing scientific evidence is inadequate to support the authors’ implication of equivalency between intravenous and intraosseous (IO) routes.2 ,3 For example, in table 1, the authors state that tranexamic acid was administered to 82 casualties with no evidence of complications. But, there is no evidence of therapeutic equivalence between IO-administered tranexamic acid and intravenously administered tranexamic acid. To date, no …
Footnotes
Correction notice The competing interests statement in this letter has been updated since it was first published online.
Competing interests MH is a Co-Founder, shareholder, and former Chair and Chief Medical Officer of Evena Med which designs and manufactures multi-spectral near infrared light imaging technology for multiple medical applications including vascular access. Evena Med is also an OEM (original equipment manufacturer) for a privately held manufacturer of point of care ultrasound technology.
Provenance and peer review Not commissioned; internally peer reviewed.